Current treatment and future directions in the management of anal cancer-Reference-Cited by-同舟云学术

Current treatment and future directions in the management of anal cancer

Published:2021-11-30 Issue: Volume: Page:
ISSN:0007-9235
Container-title:CA: A Cancer Journal for Clinicians
language:en
Short-container-title:CA A Cancer J Clin

Author:

Tchelebi Leila T.¹²^ORCID,Eng Cathy³,Messick Craig A.⁴,Hong Theodore S.⁵,Ludmir Ethan B.⁶,Kachnic Lisa A.⁷,Zaorsky Nicholas G.⁸⁹^ORCID

Affiliation:

1. Department of Radiation Medicine Zucker School of Medicine Hempstead New York

2. Department of Radiation Medicine Northwell Health Cancer Institute Mount Kisco New York

3. Department of Hematology and Oncology Vanderbilt‐Ingram Cancer Center Nashville Tennessee

4. Department of Surgical Oncology The University of Texas MD Anderson Cancer Center Houston Texas

5. Department of Radiation Oncology Massachusetts General Hospital Boston Massachusetts

6. Department of Radiation Oncology The University of Texas MD Anderson Cancer Center Houston Texas

7. Department of Radiation Oncology Columbia University Irving Medical Center New York New York

8. Department of Radiation Oncology University Hospitals Seidman Cancer CenterCase Western Reserve School of Medicine Cleveland Ohio

9. Department of Radiation Oncology Penn State Cancer Institute Hershey Pennsylvania

Publisher

Wiley

Subject

Oncology,Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.3322/caac.21712

Reference101 articles.

1. Cancer statistics, 2019

2. International trends in anal cancer incidence rates;Islami F;Int J Epidemiol,2016

3. High-sensitivity human papilloma virus genotyping reveals near universal positivity in anal squamous cell carcinoma: Different implications for vaccine prevention and prognosis

4. Surveillance Epidemiology and End Results (SEER) Program; National Cancer Institute.Cancer Stat Facts: Anal Cancer. Accessed November 1 2021.seer.cancer.gov/statfacts/html/anus.html

5. Predictors and Patterns of Recurrence After Definitive Chemoradiation for Anal Cancer

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of patients with reduced dihydropyrimidine dehydrogenase activity receiving combined 5-fluoruracil-/capecitabine-based chemoradiotherapy;Strahlentherapie und Onkologie;2024-09-04

2. Clinical application of endoscopic submucosal dissection for superficially invasive squamous cell carcinoma/high-grade squamous intraepithelial lesion involving the canal anal;Techniques in Coloproctology;2024-07-31

3. Pleasurable and problematic receptive anal intercourse and diseases of the colon, rectum and anus;Nature Reviews Gastroenterology & Hepatology;2024-05-19

4. High-tailored Anal Canal Radiotherapy (HIT-ART): Outcomes of a 10-Year Single Center Clinical Experience;In Vivo;2024

5. Trends in epidemiology and primary treatment of anal squamous cell carcinoma in the Netherlands (1990–2021);International Journal of Cancer;2023-12-27